Key result
Coexisting heart failure and AF carries poor prognosis, underscoring need for optimal anticoagulation.
This review summarizes data on guideline adherence and the prevalence of long-term anticoagulant therapy in patients with coexisting heart failure and atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May warrant closer anticoagulation monitoring in HF-AF; leaves open survival impact pending randomized trials.
Heart failure and atrial fibrillation are the most common cardiovascular conditions in clinical practice and frequently coexist. The number of patients with heart failure and atrial fibrillation is increasing every year. Nowadays the question of anticoagulant therapy for this category of patients is being discussed. In our review we summarized data on the guideline adherence and prevalence of long-term anticoagulant therapy in patients with atrial fibrillation and heart failure.
No takes yet. Share an insight, caveat, or question.
Osmolovskaya et al. (2016) conducted a review in Heart failure and atrial fibrillation. Anticoagulant therapy was evaluated. Coexisting heart failure and atrial fibrillation confer a poor prognosis with high thromboembolic risk, underscoring the critical need for optimal long-term anticoagulant therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: